OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc under contract SPE2DP26F5818 for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505013142716, as part of a delivery order issued under the base contract SPE2DX25D9900. The award was made on May 15, 2026, with the full contract value outlined in the official award documentation. This procurement is a federal action managed by the Department of Defense through its logistics arm, intended to support military medical requirements. The item is being procured without any specified set-aside classification or NAICS code, indicating it is open to unrestricted competition among qualified vendors. The place of performance and primary office address details are not provided, though the contract is administered within the United States. Information regarding the point of contact is absent, and further details can be accessed via the DIBBS portal using the provided UI link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
